| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| RECURSION PHARMACEUTICALS, INC. | Director | Class A Common Stock | 127,053 | $565,385 | $4.45 | 18 Jun 2025 | Direct |
| RECURSION PHARMACEUTICALS, INC. | Director | Stock Option (Right to Buy) | 44,031 | 18 Jun 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| RXRX | RECURSION PHARMACEUTICALS, INC. | 18 Jun 2025 | 2 | $0 | 4 | Director | 23 Jun 2025, 17:23 |
| RXRX | RECURSION PHARMACEUTICALS, INC. | 20 Nov 2024 | 8 | $0 | 4 | Director | 22 Nov 2024, 18:25 |
| RXRX | RECURSION PHARMACEUTICALS, INC. | 20 Nov 2024 | 0 | $0 | 3 | Director | 22 Nov 2024, 18:25 |